Publications by authors named "Mark Tomishima"

Claim this Profile
R
Ready-to-use iPSC-derived microglia progenitors for the treatment of CNS disease in mouse models of neuropathic mucopolysaccharidoses.
Panagiotis Douvaras, Diego F Buenaventura, Bruce Sun, Ashley Lepack, Elizabeth Baker, Mark Tomishima

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Notice to: Efficient Derivation of Functional Floor Plate Tissue from Human Embryonic Stem Cells.
Christopher A Fasano, Stuart M Chambers, Gabsang Lee, Mark J Tomishima, Lorenz Studer

Cell Stem Cell· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bringing Advanced Therapies for Parkinson's Disease to the Clinic: The Scientist's Perspective.
Mark Tomishima, Agnete Kirkeby

J Parkinsons Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells.
Anna Sole, Sandrine Grossetête, Maxime Heintzé, Loelia Babin, Sakina Zaïdi, Mark Tomishima

Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01.
Jinghua Piao, Susan Zabierowski, Brittany N Dubose, Ellen J Hill, Monalisa Navare, Mark Tomishima

Cell Stem Cell· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use.
Tae Wan Kim, Jinghua Piao, So Yeon Koo, Sonja Kriks, Sun Young Chung, Mark J Tomishima

Cell Stem Cell· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multiplex Human Pluripotent Stem Cell Platform Defines Molecular and Functional Subclasses of Autism-Related Genes.
Gustav Y Cederquist, Jason Tchieu, Scott J Callahan, Kiran Ramnarine, Sean Ryan, Mark Tomishima

Cell Stem Cell· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons.
Sarah Kishinevsky, Tai Wang, Anna Rodina, Sun Young Chung, Chao Xu, Mark J Tomishima

Nat Commun· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a drug candidate for GLIS3-associated diabetes.
Sadaf Amin, Brandoch Cook, Ting Zhou, Zaniar Ghazizadeh, Raphael Lis, Mark Tomishima

Nat Commun· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain.
Ting Zhou, Lei Tan, Gustav Y Cederquist, Yujie Fan, Brigham J Hartley, Mark Tomishima

Cell Stem Cell· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CryoPause: A New Method to Immediately Initiate Experiments after Cryopreservation of Pluripotent Stem Cells.
Karen G Wong, Sean D Ryan, Kiran Ramnarine, Siera A Rosen, Shannon E Mann, Mark J Tomishima

Stem Cell Reports· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9-guided oncogenic chromosomal translocations with conditional fusion protein expression in human mesenchymal cells.
Fabio Vanoli, Mark Tomishima, Weiran Feng, Khadija Lamribet, Loelia Babin

Proc Natl Acad Sci U S A· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bringing Neural Cell Therapies to the Clinic: Past and Future Strategies.
Stefan Irion, Susan E Zabierowski, Mark J Tomishima

Mol Ther Methods Clin Dev· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells.
Yuchen Qi, Xin-Jun Zhang, Nicolas Renier, Zhuhao Wu, Talia Atkin, Mark Tomishima

Nat Biotechnol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation of Diverse Hormone-Releasing Pituitary Cells from Human Pluripotent Stem Cells.
Bastian Zimmer, Jinghua Piao, Kiran Ramnarine, Mark J Tomishima, Viviane Tabar

Stem Cell Reports· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-SMAD Inhibition/WNT Activation-Based Methods to Induce Neural Crest and Derivatives from Human Pluripotent Stem Cells.
Stuart M Chambers, Yvonne Mica, Gabsang Lee, Lorenz Studer, Mark J Tomishima

Methods Mol Biol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural Crest Cells from Dual SMAD Inhibition.
Faranak Fattahi, Lorenz Studer, Mark J Tomishima

Curr Protoc Stem Cell Biol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency.
Ritu Kushwaha, Nirmala Jagadish, Manjunath Kustagi, Mark J Tomishima, Geetu Mendiratta

Stem Cells· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-18b and miR-518b Target FOXN1 during epithelial lineage differentiation in pluripotent cells.
Ritu Kushwaha, Venkata Thodima, Mark J Tomishima, George J Bosl, R S K Chaganti

Stem Cells Dev· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DNA replication program is altered at the FMR1 locus in fragile X embryonic stem cells.
Jeannine Gerhardt, Mark J Tomishima, Nikica Zaninovic, Dilek Colak, Zi Yan

Mol Cell· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human iPSC-based modeling of late-onset disease via progerin-induced aging.
Justine D Miller, Yosif M Ganat, Sarah Kishinevsky, Robert L Bowman, Becky Liu, Mark J Tomishima

Cell Stem Cell· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer translocations in human cells induced by zinc finger and TALE nucleases.
Marion Piganeau, Hind Ghezraoui, Anne De Cian, Lionel Guittat, Mark Tomishima

Genome Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs.
Yvonne Mica, Gabsang Lee, Stuart M Chambers, Mark J Tomishima, Lorenz Studer

Cell Rep· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZFX controls the self-renewal of human embryonic stem cells.
Sivan Harel, Edmund Y Tu, Stuart Weisberg, Manuel Esquilin, Stuart M Chambers, Mark J Tomishima

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis